Oric Pharmaceuticals Inc. is a biopharmaceutical company focused on developing targeted therapies to overcome cancer drug resistance. With a mission to improve outcomes for patients, Oric is leveraging its expertise in precision medicine to develop innovative treatments that address the underlying genetics of drug resistance. Through rigorous research and strategic partnerships, Oric aims to revolutionize cancer treatment and bring hope to those in need.
